A gynecological cancer diagnosis can be life-altering. At City of Hope, our dedicated team of experts takes an integrated, patient-centered approach to diagnose and treat ovarian, cervical, uterine (endometrial), vaginal, vulvar and fallopian tube cancers.
By working collaboratively, our clinicians and researchers transform innovative scientific discoveries into promising new treatments that are more effective against cancer with fewer side effects for the patient.
At City of Hope, our team of experts uses leading-edge methods to treat gynecologic cancers, including cervical cancer, ovarian cancer and uterine (endometrial) cancer.
City of Hope is a nationally recognized leader in gynecological cancer research. We offer access to promising treatments for cervical cancer, ovarian cancer and uterine (endometrial) cancer that are not readily available elsewhere.
We have advanced imaging technologies that can accurately pinpoint a tumor’s size, shape and location, enhancing our doctors’ detection and treatment planning capabilities.
Minimally-invasive and robotically-assisted surgical techniques that can offer optimal outcomes with less pain, reduced scarring and faster healing time.
Cytoreductive (tumor debulking) procedures can enhance radiation and chemotherapy responses and improve outcomes for early- and advanced-stage cancer patients.
Targeted radiation regimens that are sculpted to the size and shape of the tumor, focusing its impact on cancer cells while minimizing exposure to nearby normal tissues.
Specialization in heated intraperitoneal chemotherapy (HIPEC) that applies cancer drugs directly in the abdominal cavity instead of orally or through the bloodstream. This can increase the drugs’ effectiveness and improve outcomes.
Our drug development pipeline quickly identifies new cancer drugs and turns them into promising therapies for clinical trials.
Fertility-preserving options for younger patients who want to have children after cancer treatment.
All gynecologic cancer patients can participate in our survivorship program after their treatment completes. Our doctors and researchers are working to develop resources to help improve the quality of life for survivors, and all patients can participate in ongoing long-term research related to their life after cancer.
Additionally, City of Hope patients have access to our extensive team of supportive care experts, who will help you and your caregivers achieve and maintain a better quality of life during and after your cancer treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Maria de Leon, M.D., is an assistant clinical professor in City of Hope's Division of Gynecologic Oncology, specializing in diagnosis and treatment of cervical, endometrial/uterine and ovarian cancers.
Amy Hakim, M.D., is a surgical oncologist dedicated to treating gynecological cancers. In addition to providing gynecological surgery options to treat cancer, Dr. Hakim is also studying the connection these cancers’ connection to then human papillomavirus (HPV) and the HPV vaccine.
Dr. Burton’s specialties include male and female voiding dysfunction, incontinence, benign prostatic hyperplasia, bladder neck obstruction, bladder and uterovaginal prolapse, rectocele, female genitourinary reconstruction, urethral diverticulum and urinary tract fistula.